Stability of extemporaneously prepared rosuvastatin oral suspension

被引:6
作者
Zaid, Abdel Naser [1 ]
Shtayah, Rania [2 ]
Qadumi, Ayman [2 ]
Ghanem, Mashour [3 ]
Qedan, Rawan [4 ]
Daibes, Marah [4 ]
Abu Awwad, Somud [4 ]
Jaradat, Nidal [4 ]
Kittana, Naim [4 ]
机构
[1] An Najah Natl Univ, Fac Med & Hlth Sci, Nablus, Palestine
[2] Pharmacare Ltd, Dept Res & Dev, Ramallah, Palestine
[3] Pharmacare Ltd, Dept Regulatory Affairs, Ramallah, Palestine
[4] An Najah Natl Univ, Fac Med & Hlth Sci, Dept Pharm, Nablus, Palestine
关键词
extemporaneous; rosuvastatin; stability; suspension; FAMILIAL HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS; MECHANISMS; STATINS;
D O I
10.2146/ajhp160235
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. The stability of an extemporaneously prepared rosuvastatin suspension stored over 30 days under various storage conditions was evaluated. Methods. Rosuvastatin suspension was extemporaneously prepared using commercial rosuvastatin tablets as the source of active pharmaceutical ingredient. The organoleptic properties, dissolution profile, and stability of the formulation were investigated. For the stability studies, samples of the suspension were stored under 2 storage conditions, room temperature (25 degrees C and 60% relative humidity) and accelerated stability chambers (40 degrees C and 75% relative humidity). Viscosity, pH, organoleptic properties, and microbial contamination were evaluated according to the approved specifications. High-performance liquid chromatography was used for the analysis and quantification of rosuvastatin in selected samples. Microbiological investigations were also conducted. Results. The prepared suspension showed acceptable organoleptic properties. It showed complete release of rosuvastatin within 15 minutes. The pH of the suspension was 9.8, which remained unchanged during the stability studies. The microbiological investigations demonstrated that the preparation was free of any microbial contamination. In addition, the suspension showed stability within at least the period of use of a 100-mL rosuvastatin bottle. Conclusion. Extemporaneously prepared rosuvastatin 20-mg/mL suspension was stable for 30 days when stored at room temperature.
引用
收藏
页码:1579 / 1583
页数:5
相关论文
共 23 条
[1]  
[Anonymous], 2005, Validation of analytical procedures: Text and methodology Q2 (R1)
[2]  
[Anonymous], 1993, PHYS PHARM
[3]   HDL cholesterol and protective factors in atherosclerosis [J].
Assmann, G ;
Gotto, AM .
CIRCULATION, 2004, 109 (23) :8-14
[4]   Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease [J].
Badimon, Lina ;
Padro, Teresa ;
Vilahur, Gemma .
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2012, 1 (01) :60-74
[5]   Comparison of efficacy, safety, and cost-effectiveness of various statins in dyslipidemic diabetic patients [J].
Bener, Abdulbari ;
Dogan, Muzeyyen ;
Barakat, Lolwa ;
Al-Hamaq, Abdulla O. A. A. .
INDIAN JOURNAL OF PHARMACOLOGY, 2014, 46 (01) :88-93
[6]   Mechanisms of Plaque Formation and Rupture [J].
Bentzon, Jacob Fog ;
Otsuka, Fumiyuki ;
Virmani, Renu ;
Falk, Erling .
CIRCULATION RESEARCH, 2014, 114 (12) :1852-1866
[7]   Gene-environment interaction in dyslipidemia [J].
Cole, Christopher B. ;
Nikpay, Majid ;
McPherson, Ruth .
CURRENT OPINION IN LIPIDOLOGY, 2015, 26 (02) :133-138
[8]  
Devika G. S., 2011, INT J PHARM PHARM SC, V3, P311
[9]  
Eto Masaaki, 2013, Nihon Rinsho, V71, P1590
[10]  
fda, DISS TEST IMM REL SO